NORTH HOUSE SURGERY — All Prescriptions & Medications — Page 8
Practice Code: B82008 | RIPON, HG4 1HL
Showing results 351-400 of 647
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Procyclidine hydrochloride | 49 | 2,748 | £107 | -65.4% ▼ |
| Glucose | 49 | 5,080 | £431 | -5.8% ▼ |
| Carmellose sodium | 49 | 3,610 | £521 | -24.4% ▼ |
| Benzydamine hydrochloride | 49 | 9,720 | £192 | -36.6% ▼ |
| Azelaic acid | 49 | 1,470 | £286 | +105.0% ▲ |
| 48 | 203 | £1.2K | +429.0% ▲ | |
| 48 | 1,510 | £969 | +84.2% ▲ | |
| Dosulepin hydrochloride | 47 | 2,380 | £505 | -17.0% ▼ |
| Fluconazole | 47 | 223 | £90 | -39.2% ▼ |
| Medroxyprogesterone acetate | 47 | 2,144 | £468 | +22.8% ▲ |
| 47 | 406 | £1.0K | +94.0% ▲ | |
| Flecainide acetate | 46 | 2,670 | £109 | -41.1% ▼ |
| Theophylline | 46 | 2,800 | £1.4K | -45.0% ▼ |
| Tibolone | 46 | 1,512 | £143 | +50.3% ▲ |
| Enoxaparin | 45 | 1,262 | £8.0K | +119.5% ▲ |
| Flupentixol decanoate | 45 | 46 | £190 | +181.9% ▲ |
| Exemestane | 45 | 1,468 | £252 | +38.5% ▲ |
| Neomycin sulfate | 45 | 675 | £83 | -24.1% ▼ |
| Terbinafine hydrochloride | 45 | 1,365 | £256 | +21.3% ▲ |
| Ivabradine | 44 | 2,464 | £601 | -53.7% ▼ |
| Hydrocortisone acetate | 44 | 1,530 | £288 | -33.4% ▼ |
| 44 | 138 | £31 | +23.4% ▲ | |
| 44 | 1,522 | £91 | -11.8% ▼ | |
| Meloxicam | 43 | 2,268 | £59 | -35.0% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 43 | 1,500 | £622 | -35.9% ▼ |
| 43 | 105.4K | £4.6K | +12.8% ▲ | |
| Sodium picosulfate | 42 | 6,200 | £580 | +15.7% ▲ |
| Orlistat | 42 | 3,626 | £882 | -49.0% ▼ |
| Dulaglutide | 42 | 172 | £3.1K | -63.4% ▼ |
| Levonorgestrel | 42 | 42 | £3.2K | +11.3% ▲ |
| Sodium chloride | 42 | 3,320 | £2.2K | +41.2% ▲ |
| Alverine citrate | 41 | 3,228 | £176 | -0.9% vs avg |
| Sennosides | 41 | 13.6K | £261 | +32.8% ▲ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 41 | 4,100 | £188 | -77.2% ▼ |
| Testosterone undecanoate | 41 | 41 | £3.2K | +61.5% ▲ |
| Testosterone esters | 41 | 41 | £89 | +178.0% ▲ |
| Travoprost | 41 | 173 | £111 | -13.0% ▼ |
| 41 | 447 | £550 | +274.5% ▲ | |
| 41 | 2,920 | £6.2K | -15.9% ▼ | |
| 41 | 116 | £1.7K | +414.9% ▲ | |
| Diclofenac sodium | 40 | 2,228 | £316 | -21.2% ▼ |
| Leflunomide | 40 | 1,200 | £78 | +5.7% ▲ |
| 40 | 63 | £426 | +11.9% ▲ | |
| Telmisartan | 39 | 1,456 | £335 | -32.7% ▼ |
| Midodrine hydrochloride | 39 | 1,524 | £343 | -20.0% ▼ |
| Isophane insulin | 39 | 195 | £847 | -63.1% ▼ |
| Biphasic insulin aspart | 39 | 320 | £1.8K | -61.6% ▼ |
| Ergocalciferol | 39 | 1,372 | £679 | +133.0% ▲ |
| Metronidazole | 39 | 1,460 | £446 | +3.8% ▲ |
| 39 | 3,965 | £1.2K | +793.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.